Provided by Tiger Fintech (Singapore) Pte. Ltd.

ARS PHARMACEUTICALS INC

17.81
-0.0700-0.39%
Volume:452.78K
Turnover:8.03M
Market Cap:1.75B
PE:-110.76
High:17.91
Open:17.75
Low:17.51
Close:17.88
Loading ...
May 09, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 09, 2024

Major Issues Report

Form 8-K - Current report
Mar 29, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Mar 21, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 21, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 21, 2024

Major Issues Report

Form 8-K - Current report
Mar 07, 2024

Major Issues Report

Form 8-K - Current report
Feb 27, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 27, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 10, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 10, 2023

Major Issues Report

Form 8-K - Current report
Sep 26, 2023

Major Issues Report

Form 8-K - Current report
Sep 25, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Sep 20, 2023

Major Issues Report

Form 8-K - Current report
Sep 02, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Sep 01, 2023

Beneficial Ownership Change

Form SC 13D - General statement of acquisition of beneficial ownership
Sep 01, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 11, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 10, 2023

Major Issues Report

Form 8-K - Current report
Aug 01, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities